Abstract
We describe a case of reactivation of hepatitis D virus (HDV) in a patient treated with chemotherapy for a diffuse large B cell lymphoma despite lamivudine prophylaxis. This case suggests that previously cleared HDV should be considered when administering chemotherapy to patients with lymphoma.
Originalsprog | Engelsk |
---|---|
Tidsskrift | International Journal of Hematology |
Vol/bind | 92 |
Udgave nummer | 2 |
Sider (fra-til) | 378-80 |
Antal sider | 3 |
ISSN | 0925-5710 |
DOI | |
Status | Udgivet - 1 sep. 2010 |